The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An armored GPC3-directed CAR-T for refractory or relapsed hepatocellular carcinoma in China: A phase I trial.
 
Zhongwei Zhao
No Relationships to Disclose
 
Wenyuan Guo
No Relationships to Disclose
 
Shiji Fang
No Relationships to Disclose
 
Shaohua Song
No Relationships to Disclose
 
Jingjing Song
No Relationships to Disclose
 
Fei Teng
No Relationships to Disclose
 
Liyun Zheng
No Relationships to Disclose
 
Jianting Mao
No Relationships to Disclose
 
Hao Guo
Employment - Hao Guo
Research Funding - Hao Guo
Patents, Royalties, Other Intellectual Property - Hao Guo
 
Wang Huajing
Employment - Wang Huajing
Research Funding - Wnag huajing
 
Xiaofeng Feng
Employment - Xiaofeng Feng
Research Funding - Xiaofeng Feng
 
xiaowen he
Employment - Origincell Therapeutics
Leadership - Origincell Therapeutics
Research Funding - Origincell Therapeutics
Patents, Royalties, Other Intellectual Property - I have a patent pending related to the technology used in the abstract.
 
Guoshan Ding
No Relationships to Disclose
 
Jiansong Ji
No Relationships to Disclose